Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Takahiro Suetomi is active.

Publication


Featured researches published by Takahiro Suetomi.


International Journal of Urology | 2010

Real-time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data.

Tomoaki Miyagawa; Satoru Ishikawa; Tomokazu Kimura; Takahiro Suetomi; Masakazu Tsutsumi; Toshiyuki Irie; Masanao Kondoh; Tsuyoshi Mitake

Objectives:  To evaluate the effectiveness of the medical navigation technique, namely, Real‐time Virtual Sonography (RVS), for targeted prostate biopsy.


International Journal of Urology | 2002

Clinical study of varicocele: statistical analysis and the results of long-term follow-up.

Mizuki Onozawa; Fumiyasu Endo; Takahiro Suetomi; Hitoshi Takeshima; Hideyuki Akaza

Background: The results of clinical examinations of varicocele and the clinical outcome of varicocelectomy conducted at Tsukuba University Hospital, Tsukuba City, Japan were analyzed.


The Journal of Sexual Medicine | 2008

Negative Impact of Metabolic Syndrome on the Responsiveness to Sildenafil in Japanese Men

Takahiro Suetomi; Koji Kawai; Shiro Hinotsu; Akira Joraku; Takehiro Oikawa; Noritoshi Sekido; Naoto Miyanaga; Toru Shimazui; Hideyuki Akaza

INTRODUCTION Several recent studies suggested that the prevalence of erectile dysfunction (ED) was higher in men with metabolic syndrome (MS). AIM We analyzed the impact of MS on the responsiveness to sildenafil. METHODS A total of 133 ED patients were evaluated for the prevalence of MS and graded on severity of ED. MS was diagnosed according to the International Diabetes Federation (IDF) definition. The severity of ED was evaluated by the International Index of Erectile Function (IIEF) questionnaire. Hormonal parameters were measured for all patients, and the IIEF questionnaire was conducted after administration of eight tablets of 50-mg doses of sildenafil. If the scores to questions 3 and 4 of the IIEF were 4 or higher after administration, the patients were defined as responders to sildenafil. MAIN OUTCOME MEASURES To clarify the negative impact of MS on the responsiveness to sildenafil. RESULTS The mean age of the patients was 56.9 years, and 25 patients were diagnosed with MS. The IIEF-erectile function score and the response rate for sildenafil decreased as the number of MS components increased. Logistic regression analysis showed that the presence of MS along with severity of ED and history of pelvic surgery were significant independent risk factors of nonresponse for sildenafil. The hazard ratio for the presence of MS was 3.30 (95% confidence interval [CI]: 1.17-9.73). No meaningful association was observed between total testosterone or free testosterone levels and MS in this population. CONCLUSION We demonstrated the negative impact of MS on the responsiveness to sildenafil. Erectile function and response rate for sildenafil decreased as the number of MS components increased.


Neurobiology of Aging | 2006

Age-related alteration of neurturin receptor GFRa2 and nNOS in pelvic ganglia.

Shin-ichi Hisasue; Ryuichi Kato; Takahiro Suetomi; Kazunori Kato; Kazuhiro Suzuki; Ko Kobayashi; Naoki Itoh; Hiroshi Kiyama; Taiji Tsukamoto

Neurturin is a neurotrophic factor that is widely expressed in cavernous tissue and retrogradely transported to penis-projecting neurons via its receptor, glial cell line derived neurotrophic factor family receptor alpha-2 (GFRa2). To investigate the influence of aging on neural function on the penis, we examined the expression of GFRa2 mRNA in the major pelvic ganglion and its relationship to neuronal nitric oxide synthase (nNOS)- and tyrosine hydroxylase (TH)-positive neurons. GFRa2 and nNOS mRNA expression levels in RT-PCR showed age-related decreases in 1-, 3-, 6-, 12-, 18- and 24-month-old rats. In situ hybridization also revealed that the number of GFRa2-positive neurons in pelvic ganglia decreased with aging. A double-labeling study revealed the co-expression of GFRa2 and nNOS, which simultaneously decreased in old adult (24 months) and young castrated rats compared with young adult rats (3 months). These results suggest that aging and castration influence the numbers of nNOS- and GFRa2-positive neurons. Higher age might affect not only cavernous tissue but also the neural plasticity of the cavernous nerve related to erectile function.


International Journal of Urology | 2008

Alteration of glial cell line-derived neurotrophic factor family receptor alpha-2 mRNA expression and its co-expression with neuronal nitric oxide synthase in pelvic ganglia following unilateral cavernous nerve injury.

Shin-ichi Hisasue; Ryuichi Kato; Ko Kobayashi; Takahiro Suetomi; Hiroshi Kiyama; Taiji Tsukamoto

Objectives:  The goal of this study was to determine the alterations of glial cell line‐derived neurotrophic factor family receptor alpha‐2 (GFRα2) mRNA expression in the major pelvic ganglia (MPG) and their relationship to the marker for the neural plasticity (growth‐associated protein 43: GAP‐43) and neuronal nitric oxide synthase (nNOS)‐positive neurons following cavernous nerve injury.


International Journal of Urology | 2014

Expression of the oncoprotein gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumor.

Satoshi Ando; Taeko Matsuoka; Koji Kawai; Shintaro Sugita; Akira Joraku; Takahiro Kojima; Takahiro Suetomi; Jun Miyazaki; Jun Fujita; Hiroyuki Nishiyama

The oncoprotein, gankyrin, is known to facilitate cell proliferation through phosphorylation and degradation of retinoblastoma protein. In the present study, we evaluated the expression of gankyrin and phosphorylated retinoblastoma protein in human testis and testicular germ cell tumors.


Japanese Journal of Clinical Oncology | 2012

Management of Ureteral Obstruction in Advanced Testicular Tumor with Lymph Node Metastasis

Atsushi Ikeda; Koji Kawai; Satoshi Ando; Takehiro Oikawa; Hiromu Inai; Tomokazu Kimura; Eiichiro Takaoka; Takayuki Yoshino; Takahiro Suetomi; Takahiro Kojima; Jun Miyazaki; Hiroyuki Nishiyama

OBJECTIVE Ureteral obstruction is one of the complications of testicular tumor with retroperitoneal lymph node metastasis that requires ureteral stenting for management. We elucidated the clinical courses of ureteral obstructions and changes in renal functions in patients with indwelling ureteral stenting. METHODS The medical records of 56 patients who were treated for metastatic testicular tumors by chemotherapy at a single institute between 2002 and 2010 were retrospectively reviewed. RESULTS Among 56 patients, 12 patients needed ureteral stenting before chemotherapy. The proportion of patients requiring ureteral stenting was significantly higher in seminoma than non-seminoma (47 and 12%, respectively, P < 0.05). The ureteral stent was removed after chemotherapy or retroperitoneal lymph node dissection in all patients, except for one patient who died of cancer during chemotherapy. At retroperitoneal lymph node dissection, ureters were spared in three patients, a partial ureterectomy was needed in one patient, and no case underwent adjunctive nephrectomy. These 11 patients presented no local and distant recurrence at median follow-up of 44 months. Ureteral stenting increased the estimated glomerular filtration rate to more than 60 ml/min before chemotherapy in all patients, but it decreased to <60 ml/min in 6 of 11 patients after chemotherapy. CONCLUSIONS Ureteral obstruction due to testicular tumor was relieved after chemotherapy or retroperitoneal lymph node dissection. Ureteral stenting was effective to improve renal function before chemotherapy, although we should pay special attention to deterioration of renal function during or after chemotherapy.


Japanese Journal of Clinical Oncology | 2012

A Case of Acute Adrenal Insufficiency Unmasked During Sunitinib Treatment for Metastatic Renal Cell Carcinoma

Takayuki Yoshino; Koji Kawai; Jun Miyazaki; Tomokazu Kimura; Atsushi Ikeda; Eiichiro Takaoka; Takahiro Suetomi; Takehiro Oikawa; Takahiro Kojima; Hitoshi Iwasaki; Hitoshi Shimano; Hiroyuki Nishiyama

Sunitinib has recently become a standard treatment for metastatic renal cell carcinoma. However, various adverse events have been reported. We present the first case of clinically evident adrenal insufficiency during sunitinib therapy. A 72-year-old man began sunitinib therapy for bilateral lung and adrenal metastases of renal cell carcinoma. His adrenocorticotrophic hormone level was 93.6 pg/ml (7.2-63.3 pg/ml) before sunitinib treatment, indicating that subclinical adrenal insufficiency already existed. Fatigue, which is a frequently seen adverse effect of sunitinib treatment, emerged acutely on Day 24 of the second cycle. Adrenocorticotrophic hormone and free T4 were high and thyroid-stimulating hormone was suppressed. Under the clinical diagnosis of acute adrenal insufficiency with thyrotoxicosis, a low dose of steroid was administered. Fatigue was completely ameliorated by the following morning, although free T4 was still high and thyroid-stimulating hormone was still low. Therefore, hypermetabolism due to thyrotoxicosis unmasked adrenal insufficiency in our case. Physicians should be aware of this rare but potentially fatal complication when severe acute fatigue develops in patients with subclinical adrenal insufficiency.


International Journal of Urology | 2005

Evaluation of the effectiveness of sildenafil using questionnaire methods versus audio-visual sexual stimulation

Takahiro Suetomi; Fumiyasu Endo; Hitoshi Takeshima; Hideyuki Akaza

Abstract  Aim:  In the present study, an audio‐visual sexual stimulation (AVSS) test was used to evaluate the effectiveness of sildenafil, and the AVSS test was coevaluated with the international index of erectile function (IIEF) questionnaire.


International Journal of Urology | 2002

Testicular cancers occurring in brothers with cryptorchism.

Takahiro Suetomi; Koji Kawai; Noritoshi Sekido; Koji Kikuchi; Hitoshi Takeshima; Hideyuki Akaza

We report a case of familial testicular cancer associated with undescended testes in two brothers. The older brother (49 years) presented with a testicular tumor located in the right inguinal canal. The pathologic diagnosis was pure seminoma. Computerized tomography revealed iliac and retroperitoneal lymph node metastases. Four years later, the younger brother (44 years) developed bilateral testicular tumors, one located in the inguinal canal, the other located in the pelvic cavity. The pathologic diagnosis of both tumors was pure seminoma. Radiological examination revealed retroperitoneal lymph node metastases. Both patients received cisplatin‐based combination chemotherapy as the initial treatment. The older brother suffered from repeated recurrences with lymph node metastases in the iliac and inguinal regions, but he was successfully treated with high‐dose chemotherapy. The younger brother achieved long‐term remission after retroperitoneal lymph node dissection following initial chemotherapy. We briefly review the reported cases of familial testicular cancer and discuss the association of the maldescent of the testes and familial testicular cancer cases.

Collaboration


Dive into the Takahiro Suetomi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge